Not a good buy right now for an impatient investor: the primary trend is still bearish (SMA_200 > SMA_20 > SMA_5) while the stock is trading with elevated short-term momentum (RSI_6 ~75.9), which increases pullback risk.
Pre-market is already down ~-8.4% to 1.85, signaling weak near-term demand and poor tape strength heading into the open.
No Intellectia edge today: no AI Stock Picker or SwingMax entry, so there’s no strong systematic “buy now” trigger.
With earnings on 2026-02-19 (after hours) and weak recent fundamentals (revenue/margins down), risk/reward does not favor buying immediately; better to stay out (or reduce if held).
Technical Analysis
Trend: Bearish structure (SMA_200 > SMA_20 > SMA_5) suggests the broader downtrend remains intact despite any short-term bounce attempts.
Momentum: MACD histogram +0.157 and expanding indicates short-term bullish momentum, but it’s occurring within a bearish moving-average regime (often a counter-trend rally risk).
RSI: RSI_6 at ~75.86 is elevated (effectively overbought/extended), which commonly precedes consolidation or a dip—unfriendly for an impatient “buy now” entry.
Key levels: Pivot 1.679.
Near resistance: R1 2.129 (then R2 2.407).
Supports: S1 1.229 (then S2 0.951).
Pattern-based projection (from similar candlesticks): ~70% chance of ~0.08% next day, -1.44% next week, +8.71% next month—skews choppy near-term with only a speculative longer bounce case.
Positive Catalysts
and build toward 2.
Earnings date upcoming (2026-02-19 after hours) can act as a volatility catalyst if results surprise positively.
Neutral/Negative Catalysts
point to operational pressure.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 29.34M, down -19.16% YoY (negative growth trend).
Net income: -6.50M (still a loss) but improved ~+92.45% YoY (loss narrowed).
EPS: -11.27, improved +9.21% YoY but remains deeply negative.
Gross margin: 20.14%, down -40.34% YoY, a meaningful deterioration (negative quality of earnings trend).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so no recent upgrades/downgrades or target revisions can be confirmed.
Wall Street-style pros/cons view based on provided data only:
Pros: some improvement in losses YoY; possible technical bounce per positive MACD.
Cons: revenue decline, sharply weaker gross margin, bearish long-term trend, and no strong institutional/insider/congress accumulation signals reported.
Politicians/congress: No recent congress trading data available (last 90 days).
Wall Street analysts forecast BOXL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BOXL is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast BOXL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BOXL is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Buy
Hold
Sell
0
Current: 1.880
Low
0
Averages
0
High
0
0
Current: 1.880
Low
0
Averages
0
High
0
Maxim Group
Jack Vander Aarde
Strong Buy
to
Hold
Downgrades
n/a
AI Analysis
2025-04-07
Reason
Maxim Group
Jack Vander Aarde
Price Target
n/a
AI Analysis
2025-04-07
Downgrades
Strong Buy
to
Hold
Reason
Maxim analyst Jack Vander Aarde downgraded Boxlight to Hold from Buy.
